Complexbiotech · Newsroom

CBDV Expands Cannabis Testing Beyond Compliance Requirements with Industry-leading Instrumentation
An Innovative Solution to Testing Cannabis Vapor/Smoke, Plant Material, and Formulations with CBDV’s New Advanced Analytical Testing Services

January 27, 2021

CBDV Begins Research on Psilocybin with Section 56 Exemption from Health Canada
CBDV will develop analytical methods for psilocybin and identify new medicinally relevant mushroom metabolites.

January 14, 2021